OFF-BRAND IMATINIB: A BUDGET-FRIENDLY OPTION?

The introduction of common imatinib represents a substantial possibility for patients battling a certain type of cancer and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a considerable price tag, frequently causing accessibility for some individuals. Generic